Results 91 to 100 of about 99,648 (351)

Invasive bladder cancer in the eighties: transurethral resection or cystectomy?

International Brazilian Journal of Urology, 2011
PURPOSE: Describe morbidity and survival in patients older than 80 years with muscle invasive bladder cancer (MIBC) treated with radical cystectomy (RC) or transurethral resection (TUR) in our institution.
Oscar Rodriguez Faba, Joan Palou, Guillermo Urdaneta, Luis Gausa, Humberto Villavicencio   +4 more
doaj   +1 more source

Ten-Year Oncologic Outcomes Following Robot-Assisted Radical Cystectomy: Results from the International Robotic Cystectomy Consortium.

Journal of Urology, 2019
INTRODUCTION Radical cystectomy (RC) is the gold standard for non-metastatic muscle invasive bladder cancer, and for refractory non-muscle invasive disease.
A. Hussein, A. Elsayed, N. Aldhaam, Zhe Jing, J. Osei, J. Kaouk, J. Redorta, M. Menon, J. Peabody, P. Dasgupta, Mohammed Shamim Khan, A. Mottrie, M. Stöckle, A. Hemal, L. Richstone, A. Hosseini, P. Wiklund, F. Schanne, Eric H. Kim, K. Rha, K. Guru   +20 more
semanticscholar   +1 more source

Long-Term Experience of Chemoradiotherapy Combined with Deep Regional Hyperthermia for Organ Preservation in High-Risk Bladder Cancer (Ta, Tis, T1, T2). [PDF]

, 2019
BackgroundThe aim of this study was to evaluate the efficacy and safety of chemoradiotherapy (RCT) combined with regional deep hyperthermia (RHT) of high-risk bladder cancer after transurethral resection of bladder tumor (TUR-BT).Materials and ...
Bertz, Simone, Fietkau, Rainer, Gall, Christine, Haderlein, Marlen, Hartmann, Arndt, Keck, Bastian, Kühn, Reinhard, Merten, Ricarda, Ott, Oliver, Rödel, Claus Michael, Uter, Wolfgang, Weiss, Christian, Wullich, Bernd   +12 more
core  

Successful Management of Tumor Lysis Syndrome Following Enfortumab Vedotin Plus Pembrolizumab Therapy in Metastatic Urothelial Carcinoma: A Case Report

IJU Case Reports, EarlyView.
ABSTRACT Introduction Enfortumab vedotin plus pembrolizumab (EV + P) shows high efficacy in metastatic urothelial carcinoma (mUC), potentially increasing tumor lysis syndrome (TLS) risk. Case Presentation A 64‐year‐old man with mUC underwent surgery and adjuvant nivolumab after neoadjuvant chemotherapy.
Daigo Takemori, Ryu Shigehisa, Sho Shimasaki, Erika Yamashita, Yoshitaka Kurano, Kaya Atagi, Yuhi Ota, Shinkuro Yamamoto, Hiroto Osakabe, Tomoya Nao, Tsutomu Shimamoto, Hideo Fukuhara, Nobutaka Shimizu, Satoshi Fukata, Shingo Ashida, Keiji Inoue   +15 more
wiley   +1 more source

Workup and conservative management of ileal conduit-vaginal fistulas: review of literature. [PDF]

, 2020
Ileal conduit-vaginal fistulas are a rare but challenging complication of urinary diversion. Here we identify risk factors and summarize the workup and conservative management strategies for this complication.
Chowdhury, Mashrin Lira, Ghoniem, Gamal, Palmer, Cristina, Shen, Aricia   +3 more
core  

Thermal dosimetry for bladder hyperthermia treatment. An overview. [PDF]

, 2016
The urinary bladder is a fluid-filled organ. This makes, on the one hand, the internal surface of the bladder wall relatively easy to heat and ensures in most cases a relatively homogeneous temperature distribution; on the other hand the variable volume,
Bakker, Akke, Balidemaj, Edmond, Chopra, Rajiv, Crezee, Johannes, Geijsen, Elisabeth D., Hartmann, Josefin, Hulshof, Maarten C.C.M., Kok, H. Petra, Maccarini, Paolo F., Paulides, Margarethus M., Schooneveldt, Gerben, Sousa-Escandon, Alejandro, Stauffer, Paul R.   +12 more
core   +3 more sources

A Case of Renal Metastasis of Urothelial Carcinoma With Trophoblastic Differentiation Successfully Treated With Robot‐Assisted Partial Nephrectomy

IJU Case Reports, EarlyView.
ABSTRACT Introduction There are no previous reports of solitary renal metastases from urothelial carcinoma with trophoblastic differentiation, a rare bladder cancer subtype that is pathologically hCGβ positive. Case Presentation A 77‐year‐old male with urothelial carcinoma with trophoblastic differentiation underwent robot‐assisted radical cystectomy ...
Seiichiro Honda, Koichi Uemura, Hiroki Ito, Erika Muraoka, Tomoyuki Tatenuma, Yusuke Ito, Kentaro Muraoka, Hisashi Hasumi, Naomi Kawano, Shoji Yamanaka, Kazuhide Makiyama   +10 more
wiley   +1 more source

Radical Cystectomy in the Treatment of Bladder Cancer: Oncological Outcome and Survival Predictors

Journal of the Formosan Medical Association, 2009
To better understand the result of radical cystectomy in the treatment of bladder cancer, we analyzed our data and reported the oncological outcomes and survival predictors.
Chen-Hsun Ho, Chao-Yuan Huang, Wei-Chou Lin, Shih-Chieh Chueh, Yeong-Shiau Pu, Ming-Kuen Lai, Hong-Jeng Yu, Kuo-How Huang   +7 more
doaj   +1 more source

Left ileal conduit: A case report

IJU Case Reports, 2020
Introduction When ileal conduit construction is performed for urinary tract drainage during radical cystectomy, the conduit is usually constructed in the right lower abdomen. However, no reports have described ileal conduit construction in the left lower
Kazuyoshi Nakamura, Kenichiro Matsui, Ken Wakai, Tomokazu Sazuka, Yusuke Imamura, Shinichi Sakamoto, Nobuyuki Sekita, Tomohiko Ichikawa   +7 more
doaj   +1 more source

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer [PDF]

, 2019
BACKGROUND: Local-regional failure (LF) for locally advanced bladder cancer (LABC) after radical cystectomy (RC) is common even with chemotherapy and is associated with high morbidity/mortality.
Andriole, Gerald L, Arora, Vivek, Baumann, Brian C, Bullock, Arnold, DeWees, Todd A, et al,, Figenshau, Robert S, Fischer-Valuck, Benjamin W, Gay, Hiram A, Grubb, Robert L, Kim, Eric, Knoche, Eric M, Michalski, Jeff M, Pachynski, Russell K, Roth, Bruce J, Smith, Zachary L   +15 more
core   +2 more sources